-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $31

Benzinga·03/20/2026 17:57:02
Listen to the news
B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $26 to $31.